期刊文献+

人血清CA15-3化学发光免疫分析方法的建立及应用 被引量:1

Development of a Method of Chemiluminescence Immunoassay for CA15-3 with Native Produced Apparatus and Kits in This Laboratory
下载PDF
导出
摘要 目的:建立人血清CA15-3化学发光免疫分析方法并在临床检测中的应用。方法:使用CA15-3定量测定试剂盒(化学发光法)检测1232例,其中754例正常人及478例病人血清标本,并与CA15-3电化学发光全自动免疫分析方法进行对比。结果:灵敏度0.032KU/L,线性范围1.2~160KU/L,与CA125及CEA无交叉反应,样本中抗凝剂量的柠檬酸钠、肝素、EDTA-Na2对测定结果没有影响。添加回收率和稀释回收率为90%~110%,分析内和分析间变异均〈10.0%。该方法正常参考值为(0~23.08)KU/L(95%可信限)。ECLA测定结果与本法相比,临床总符合率为96.65%。结论:该方法灵敏度高、特异性好、稳定性强、检测范围宽,有良好的准确性和重复性,完全可以替代进口化学发光试剂用于临床样本的检测。 Objective To establish a method of chemiluminescence immunoassay (CLIA) developed in this laboratory for serum CA15 - 3 determination with native produced apparatus and kits. Methods Serum CA15 - 3 contents were determined with CLIA, using native made apparatus and kits developed in our laboratory. Altogether 1232 specimens were tested (478 from patients and 754 from controls); the results were compared with those obtained with Roche - Elecsys 2010. Results The sensitiveity of the assay was 0.034KU/L. Linear range was 1.2~160KU/L. There were no cross - reactions with CA125 and CEA. Adding necessary amount of anticoagulants (sodium citrate, heparin, EDTA - Na2) to the specimen had no effect on the assay results. Additional or dilutional recovery rate was 90%~110%. Both the inter and intra - CV were less than 10.0%. Normal range of CA15 - 3 concentration with this method was (0~23.08 )KU/L (95% confidence limit). Results of this assay had a coincidence rate of 96.65% to those with the gold - standard Elecsys 2010 ECLIA. Conclusion The newly developed method of CLIA was sensitive, specific stable, accurate with good reproducibility. The imported apparatus and kits could be adequately replaced.
出处 《放射免疫学杂志》 CAS 2006年第5期429-431,共3页 Journal of Radioimmanology
关键词 化学发光免疫分析 糖类抗原CA15-3 chemiluminescence immunoassay, CA15 - 3
  • 相关文献

参考文献6

二级参考文献6

共引文献83

同被引文献4

  • 1Finn OJ, Jerome KR, Henderson RA, Pecher G, Domenech N Magarian-Blander J, Simon M, Barratt-Boyes. MUC-1 Epitheli al Tumor Mucin-Based Immunity and Cancer Vaccines[J]. Im mun Rev,1995,145(1) :61-89.
  • 2Meisel M, Straube W, Versumer C. Time course of tumor markers MSA, CA15-3, and CA549 in patients with breast cancer. Klapdor R, eds. Current tumor diagnosis., applications, clinical relevance, research, trends [M]. New York.. W Zuck-schwerdt Verlag, 1994: 149-151.
  • 3汤剑猷.现代肿瘤学[M].上海:上海医科大学出版社,1993.439.
  • 4陈智,周范振,符杨剑,许杨,田征宇.肿瘤标志物CA15-3的免疫放射分析及其临床应用[J].中华肿瘤杂志,1998,20(2):125-128. 被引量:82

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部